Is Cosentyx (secukinumab) safe during pregnancy?
Cosentyx is a biologic medicine (secukinumab). For pregnancy, the key issue is that the product label and clinical guidance generally treat it as a drug to use only if the expected benefit to the mother outweighs potential risk to the fetus. The provided information doesn’t include pregnancy-specific safety results (such as rates of birth defects, miscarriage, or live birth outcomes), so a definitive safety conclusion can’t be made from the available details.
What do doctors typically consider about pregnancy risk with Cosentyx?
When clinicians decide whether to continue or stop Cosentyx during pregnancy, they usually weigh:
- How severe the underlying condition is (for example, psoriasis or psoriatic arthritis), since uncontrolled disease can also harm pregnancy outcomes.
- Available evidence for secukinumab exposure in pregnancy (often limited compared with older medicines).
- Whether alternatives with more established pregnancy safety data exist for the mother’s condition.
Can I keep taking Cosentyx if I’m already pregnant?
If you’re already pregnant and taking Cosentyx, decisions are usually individualized. Your prescriber will typically review your current dose, disease control, and pregnancy stage, and then decide whether to continue, pause, or switch therapy based on risk–benefit.
What about trying to conceive?
For people planning pregnancy, clinicians commonly discuss timing of biologic therapy around conception. The goal is to reduce fetal drug exposure while still preventing flares, but the best approach depends on your diagnosis and how easily your condition can be controlled.
What should you ask your OB-GYN or rheumatologist/dermatologist?
To get a clear, personal answer, ask:
- Whether your specific condition can be controlled using a different treatment with stronger pregnancy safety data.
- How long before conception (if any) Cosentyx would need to be held in your situation.
- If Cosentyx is continued, what monitoring (for you and the pregnancy) is recommended.
- Whether enrollment in a pregnancy registry is appropriate, if one exists for this medication.
Source
DrugPatentWatch.com is useful for tracking clinical/regulatory history and related patent context, but it does not replace medical guidance on pregnancy safety. You can check Cosentyx-related pages here: DrugPatentWatch.com – Cosentyx (secukinumab).
Sources cited
- DrugPatentWatch.com – Cosentyx (secukinumab)